SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)] [amend]
SEC Accession No. 0001144204-12-039394
Filing Date
2012-07-13
Accepted
2012-07-13 16:01:19
Documents
11
Period of Report
2011-06-30
Filing Date Changed
2012-07-13

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-Q v317701_10qa.htm 10-Q/A 574422
2 EXHIBIT 31.1 v317701_ex31-1.htm EX-31.1 10790
3 EXHIBIT 31.2 v317701_ex31-2.htm EX-31.2 10242
4 EXHIBIT 32.1 v317701_ex32-1.htm EX-32.1 4216
5 EXHIBIT 32.2 v317701_ex32-2.htm EX-32.2 4281
  Complete submission text file 0001144204-12-039394.txt   2552269

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mslp-20110630.xml EX-101.INS 382316
7 XBRL TAXONOMY EXTENSION SCHEMA mslp-20110630.xsd EX-101.SCH 13446
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mslp-20110630_cal.xml EX-101.CAL 34741
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mslp-20110630_def.xml EX-101.DEF 80965
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mslp-20110630_lab.xml EX-101.LAB 115121
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mslp-20110630_pre.xml EX-101.PRE 95952
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-53166 | Film No.: 12961947
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1